NCT05395169

Brief Summary

Hypothesis: There will be no effect of the DASH diet and aerobic exercise on premenstrual syndrome. Statement of the problem: Do the DASH diet and aerobic exercise have an effect on premenstrual syndrome?

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 27, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

May 27, 2022

Status Verified

May 1, 2022

Enrollment Period

3 months

First QC Date

May 24, 2022

Last Update Submit

May 24, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Visual analogue scale (VAS)

    Visual analogue scale (VAS): Degrees of menstrual pain will be assessed using a VAS for all participants in both groups (A\&B) before and after treatment, which is a method of representing .participants pain on a 10 cm linear scale. A score of zero mean "a very low degree of pain" and 10 mean "a very high degree of pain"

    assessment will be take 12 weeks

  • Menstrual Distress Questionnaire (MDQ)

    Menstrual Distress Questionnaire (MDQ): The subjects decreased activity, lower back pain, tension or anxiety, breast tenderness, and headaches will assess for all participants in both group before and after treatment using Menstrual Distress Questionnaire (MDQ) .Each item will be score on a 5-point likert scale ,with 1 being "no pain at all" follow by "mild pain", "moderate pain", "slightly sever pain" ,and "extremely severe pain.

    assessment will be take 12 weeks

Study Arms (2)

medical treatment

EXPERIMENTAL

Control group:Will be consisted of 25 females suffering from PMS will receive medical treatment in form of vit, B6, ca supplements and minerals (vitatron), once daily(1capsule), for 12 weeks.

Other: dietary supplement ,electronic treadmill ,DASH diet.

the same medication, in addition to DASH diet and aerobic exercise

EXPERIMENTAL

Study group: Will be consisted of 25 females suffering from PMS will Receive the same medication as in group (A) in addition to the DASH diet and aerobic exercise for 30 minutes,3 times/week,for 12 weeks.

Other: dietary supplement ,electronic treadmill ,DASH diet.

Interventions

Control group Will be receive medical treatment for 12 weeks. Study group Will be receive the same medication as in control group in addition to DASH diet and aerobic exercise for 12 weeks.

medical treatmentthe same medication, in addition to DASH diet and aerobic exercise

Eligibility Criteria

Age15 Years - 25 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Fifty adolescent females were diagnosed with premenstrual syndrome.
  • Their age will be ranged from 15-to 25 years (3 years post-puberty).
  • Their body mass index (BMI) will range from 18-25.9 kg/m2.
  • All are of regular menstrual cycles.
  • All of them suffer from moderate and severe PMS.

You may not qualify if:

  • Any pathologic findings in the pelvic cavity as a polycystic ovarian syndrome, endometriosis, and pelvic inflammatory diseases.
  • Having irregular menstruation.
  • Any metabolic diseases.
  • Any history of gynecological intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Premenstrual Syndrome

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Azaa Barmoud, professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
specialist physical therapist at Al Delangat Hospital

Study Record Dates

First Submitted

May 24, 2022

First Posted

May 27, 2022

Study Start

June 1, 2022

Primary Completion

September 1, 2022

Study Completion

October 1, 2022

Last Updated

May 27, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF